Autosomal recessive bestrophinopathy conceivably should be amenable to a similar therapeutic approach, and a recent study using gene therapy to treat the canine model of BEST1-associated retinopathy confirmed this.11 This evidence concerns the gene BEST1 and autosomal recessive bestrophinopathy.